Profile

Ted Heise, PhD, RAC

Contact Details

United States

Contributions

1 to 5 of 50+ total
Posted By Ted Heise 28-Jun-2023 08:39
Found In Egroup: Regulatory Open Forum
\ view thread
My pet peeve was Seven Resourcing Limited. They kept changing domain names and thus evading any filters I would set. After several requests to remove my personal information from their database, I reported them to a European regulator for violations of GDPR (Seven is based, or has affiliates in Europe). ...
Posted By Ted Heise 16-May-2023 09:19
Found In Egroup: Regulatory Open Forum
\ view thread
I think the below is correct for a 510(k) cleared device, but for a device approved under PMA a submission is required... https://www.fda.gov/medical-devices/premarket-approval-pma/pma-frequently-asked-questions#5
Posted By Ted Heise 15-May-2023 09:16
Found In Egroup: Regulatory Open Forum
\ view thread
Hi Anon, It really depends on your circumstances. Be aware (if you're not already) that effectively executing clinical studies takes a great deal of resources-especially if they need to be in conformance to GCP or ISO 14155. If you are part of a growing company that expects to be carrying out multiple ...
Posted By Ted Heise 15-May-2023 09:10
Found In Egroup: Regulatory Open Forum
\ view thread
Hi Anon, Based on experience from something like a hundred CERs written at MED, I agree with the advice you got from Richard and Stephanie, as well as your posted thinking: the company's internal data is almost certainly more detailed than what is in the publication, and those details (as applicable) ...
Posted By Ted Heise 10-May-2023 09:04
Found In Egroup: Regulatory Open Forum
\ view thread
Good info from Dan, as usual. I'd add that in most cases a manufacturer will have had a number of inquiries from CDRH's signals management group before being slapped with a 522 order. This tool is usually (always?) applied to 510(k) cleared products. It's also relevant to note that postmarket requirements ...